Abstract LB-234: Poxvirus-based active immunotherapy synergizes with PD-1 plus LAG-3 immune checkpoint inhibition to enhance antitumor efficacy in preclinical models

MLA

Veronica Xavier, et al. “Abstract LB-234: Poxvirus-Based Active Immunotherapy Synergizes with PD-1 plus LAG-3 Immune Checkpoint Inhibition to Enhance Antitumor Efficacy in Preclinical Models.” Cancer Research, vol. 75, Aug. 2015, p. LB-234. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........6278ca339b146bae6f3a57269ab99717&authtype=sso&custid=ns315887.

APA

Veronica Xavier, Susan P. Foy, James Bradley Breitmeyer, Ryan Rountree, Evan Gordon, Barbara Sennino, Alex Franzusoff, Stefanie Mandl, Tracy dela Cruz, & Felicia Kemp. (2015). Abstract LB-234: Poxvirus-based active immunotherapy synergizes with PD-1 plus LAG-3 immune checkpoint inhibition to enhance antitumor efficacy in preclinical models. Cancer Research, 75, LB-234.

Chicago

Veronica Xavier, Susan P. Foy, James Bradley Breitmeyer, Ryan Rountree, Evan Gordon, Barbara Sennino, Alex Franzusoff, Stefanie Mandl, Tracy dela Cruz, and Felicia Kemp. 2015. “Abstract LB-234: Poxvirus-Based Active Immunotherapy Synergizes with PD-1 plus LAG-3 Immune Checkpoint Inhibition to Enhance Antitumor Efficacy in Preclinical Models.” Cancer Research 75 (August): LB-234. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........6278ca339b146bae6f3a57269ab99717&authtype=sso&custid=ns315887.